Oxford Trial Vaccine To Be Called Covishield In India
The Oxford vaccine, so far tested with promising results, could be made available in India by November. The Serum Institute of India, which took a huge gamble on the Oxford vaccine even before the results started coming out, is hopeful of a bright future. On the show, an exclusive interview with Adar Poonawalla, CEO and Owner of Serum Institute of India. (Video courtesy: University of Oxford)
